Publicaciones (380) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. BCL2 translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 101-108

  2. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  3. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  4. A Novel Approach for the Shape Characterisation of Non-Melanoma Skin Lesions Using Elliptic Fourier Analyses and Clinical Images

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  5. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  6. A Systems Biology- and Machine Learning-Based Study to Unravel Potential Therapeutic Mechanisms of Midostaurin as a Multitarget Therapy on FLT3-Mutated AML

    BioMedInformatics, Vol. 2, Núm. 3, pp. 375-397

  7. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  8. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1248-1255

  9. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström’s macroglobulinemia

    Leukemia and Lymphoma, Vol. 63, Núm. 5, pp. 1058-1069

  10. A quantitative systems approach to define novel effects of tumour p53 mutations on binding oncoprotein mdm2

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  11. A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

    Blood cancer journal, Vol. 12, Núm. 4, pp. 68

  12. A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper

    Clinical and Translational Oncology, Vol. 24, Núm. 6, pp. 968-980

  13. A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions

    Cell Death and Differentiation, Vol. 29, Núm. 12, pp. 2347-2361

  14. ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S369-S370

  15. ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S199

  16. Abordaje de los accesos vasculares en intervencionismo en cardiopatía estructural

    REC: Interventional Cardiology, Vol. 4, Núm. 4, pp. 311-318

  17. Acute esophageal necrosis induced by immune checkpoint inhibitors

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183

  18. Acute leukemia of mixed phenotype: presentation of a pediatric case from Peru

    Revista Cubana de Hematologia, Inmunologia y Hemoterapia, Vol. 38, Núm. 1

  19. Adaptation and validation of the Spanish version of the everyday cognition battery for assessing everyday cognition in older adults

    BMC Geriatrics, Vol. 22, Núm. 1

  20. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

    The Lancet. Haematology, Vol. 9, Núm. 6, pp. e403-e414